The NeoTYPE Lung Tumor Profile analyzes 46 biomarkers through a combination of next-generation sequencing (NGS), other molecular methods, FISH, and IHC. The NeoTYPE Lung Tumor Profile characterizes primary or metastatic non-small cell tumors for the most significant genetic changes relevant to therapy decisions, prognosis, and clinical research. It is appropriate for patients with newly-diagnosed or recurrent disease, and for patients with resistant disease to explore options in clinical trials.
Lung Cancer
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), ARID1A (AT-rich interaction domain 1A), ATM (ATM serine/threonine kinase), ATR (Ataxia telangiectasia and Rad3-related protein), ATRX (ATRX Chromatin Remodeler)
See More ...
Next-Generation Sequencing (NGS) / Immunohistochemistry (IHC) / FISH